3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
33
OTHER_GOV
3
INDUSTRY
2
UNKNOWN
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
21
Stomach Neoplasms
14
Colorectal Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Rectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Small Cell Lung Carcinoma
4
Lymphoma, Extranodal NK-T-Cell
4
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Brain Neoplasms
4
Neoplasms
3
Neoplasm Metastasis
3
Head and Neck Neoplasms
3
Vomiting
2
Sarcoma
2
Recurrence
2
Nasopharyngeal Carcinoma
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
HER2-positive Breast Cancer
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Carcinoma of Lung
1
Radiation Injuries
1
Platinum-resistant Recurrent Ovarian Cancer
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pain
1
Ovarian Neoplasms
1
Interventions
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
UNKNOWN
×
Meningeal Carcinomatosis
×
Clear all
NCT02654106
2017-06-06
SRTRBM
ChineseAMS
Phase 2
Completed
65 enrolled